Oxycodone combined with opioid receptor antagonists: efficacy and safety

Expert Opin Drug Saf
May 2013
https://pubmed.ncbi.nlm.nih.gov/23534906/

Introduction: A mu receptor antagonist combined with oxycodone (OXY) may improve pain control, reduce physical tolerance and withdrawal, minimizing opioid-related bowel dysfunction and act as an abuse deterrent.

Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects

Eur J Pain
March 2011
https://www.ncbi.nlm.nih.gov/pubmed/20728384

Erythromelalgia in a Patient with Mast Cell Activation Syndrome: Response to Low Dose Naltrexone

Skin
08 May 2019
https://jofskin.org/index.php/skin/article/view/722

Erythromelalgia is a rare condition that may be associated with a variety of underlying conditions and is often refractory to therapy. We report a case of a patient with mast cell activation syndrome who developed erythromelalgia and responded to low dose naltrexone.

Proceedings #47: Low Dose Naltrexone: A Viable Alternative for Long Term Chronic Pain?

Brain Stimulation
01 March 2019
https://www.brainstimjrnl.com/article/S1935-861X(18)30634-X/pdf

Transition of Patients With Opioid Use Disorder From Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens

American Journal on Addictions
04 April 2020
https://onlinelibrary.wiley.com/doi/full/10.1111/ajad.13024

129 Medication Assisted Treatment Protocol

Cambridge University Press
24 April 2020
https://pubmed.ncbi.nlm.nih.gov/32375158/

Naltrexone Hydrochloride 1.5-mg and 4.5-mg Capsules

US Pharm
19 March 2020
https://www.uspharmacist.com/article/naltrexone-hydrochloride-15mg-and-45mg-capsules

Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia

Biomedicines
18 April 2017
https://pubmed.ncbi.nlm.nih.gov/28536359/

Treating chronic pain with low dose naltrexone and ultralow dose naltrexone: a review paper

Journal of Pain Management and Therapy
01 February 2019
https://www.alliedacademies.org/articles/treating-chronic-pain-with-low-dose-naltrexone-and-ultralow-dose-naltrexonea-review-paper-11183.html

Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes

Am J Hosp Palliat Care
October 2019
https://pubmed.ncbi.nlm.nih.gov/30917675/